Skip to main content
Retour
Watch Compare

LifeMD, Inc.

Qualité des données : 100%
Également cotée sous LFMDP Nasdaq
LFMD
Nasdaq Services Health Services
3,41 €
▼ 0,07 € (-1,87%)
Cap. Boursière: 163,35 M
Prix
3,41 €
Cap. Boursière
163,35 M
Fourchette du Jour
3,37 € — 3,54 €
Fourchette 52 Semaines
2,56 € — 15,84 €
Volume
649 804
Ouverture 3,45 €
Moyenne 50J / 200J
3,36 €
1,33% above
Moyenne 50J / 200J
5,86 €
41,94% below

Quick Summary

Points Clés

Revenue grew 20,23% annually over 5 years — strong growth
Generating 6,41 M in free cash flow
P/E of 11,38 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 28,89%
Capital efficient — spends only 0,96% of revenue on capex

Croissance

Revenue Growth (5Y)
20,23%
Au-dessus de la moyenne du secteur (19,14%)
Revenue (1Y)-8,66%
Earnings (1Y)N/A
FCF Growth (3Y)-13,75%

Qualité

Return on Equity
N/A
ROIC-62,62%
Net Margin7,40%
Op. Margin-3,95%

Sécurité

Debt / Equity
N/A
Current Ratio0,73
Interest Coverage-5,64

Valorisation

PE (TTM)
11,38
Au-dessus de la moyenne du secteur (-0,01)
P/B Ratio124,28
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (20 pairs)
Métrique Action Médiane du Secteur
P/E 11,4 0,0
P/B 124,3 3,1
ROE % — -1,5
Net Margin % 7,4 -0,3
Rev Growth 5Y % 20,2 19,1
D/E — 1,0

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,08% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8,66% Revenue Growth (3Y) 12,79%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 20,23% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 194,06 M Net Income (TTM) 14,35 M
ROE N/A ROA 20,57%
Gross Margin 85,72% Operating Margin -3,95%
Net Margin 7,40% Free Cash Flow (TTM) 6,41 M
ROIC -62,62% FCF Growth (3Y) -13,75%
Safety
Debt / Equity N/A Current Ratio 0,73
Interest Coverage -5,64 Asset Turnover 2,78
Working Capital -15,58 M Tangible Book Value -243 984
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 11,38 Forward P/E N/A
P/B Ratio 124,28 P/S Ratio 0,84
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 3,92%
Market Cap 163,35 M Enterprise Value 163,35 M
Per Share
EPS (Diluted TTM) 0,25 Revenue / Share 4,05
FCF / Share 0,13 OCF / Share 0,17
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,96% FCF Conversion 44,65%
SBC-Adj. FCF -3,83 M Growth Momentum -28,89

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 194,06 M 212,45 M 152,55 M 119,03 M 92,88 M
Net Income 14,35 M -18,88 M -20,60 M -45,54 M -60,90 M
EPS (Diluted) 0,25 — — — —
Gross Profit 166,34 M 188,39 M 133,65 M 100,37 M 74,88 M
Operating Income -7,67 M -16,14 M -14,49 M -43,45 M -54,30 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1,36 M 2,18 M 2,60 M 1,28 M 3,02 M
Income Tax 45 721,0 402 000,0 428 000,0 360 700,0 7 700,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 70,41 M 72,46 M 58,48 M 25,67 M 49,92 M
Total Liabilities 47,25 M 76,51 M 52,91 M 32,97 M 24,10 M
Shareholders' Equity 23,16 M -5,49 M 3,51 M -11,40 M 22,74 M
Total Debt — — — — —
Cash & Equivalents — 35,00 M 33,15 M 3,96 M 41,33 M
Current Assets 51,83 M 48,73 M 42,60 M 11,31 M 44,92 M
Current Liabilities 41,57 M 60,26 M 34,78 M 31,37 M 22,83 M